227 related articles for article (PubMed ID: 20021212)
1. CXCL8 and its cognate receptors in melanoma progression and metastasis.
Singh S; Singh AP; Sharma B; Owen LB; Singh RK
Future Oncol; 2010 Jan; 6(1):111-6. PubMed ID: 20021212
[TBL] [Abstract][Full Text] [Related]
2. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
[TBL] [Abstract][Full Text] [Related]
3. The CXCL8-CXCR1/2 pathways in cancer.
Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
[TBL] [Abstract][Full Text] [Related]
4. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.
Mishra A; Suman KH; Nair N; Majeed J; Tripathi V
Mol Biol Rep; 2021 Sep; 48(9):6551-6561. PubMed ID: 34426905
[TBL] [Abstract][Full Text] [Related]
5. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.
Ha H; Debnath B; Neamati N
Theranostics; 2017; 7(6):1543-1588. PubMed ID: 28529637
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype.
Varney ML; Li A; Dave BJ; Bucana CD; Johansson SL; Singh RK
Clin Exp Metastasis; 2003; 20(8):723-31. PubMed ID: 14713106
[TBL] [Abstract][Full Text] [Related]
7. The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis.
Bie Y; Ge W; Yang Z; Cheng X; Zhao Z; Li S; Wang W; Wang Y; Zhao X; Yin Z; Li Y
Dis Markers; 2019; 2019():8023460. PubMed ID: 31827643
[TBL] [Abstract][Full Text] [Related]
8. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma.
Varney ML; Johansson SL; Singh RK
Am J Clin Pathol; 2006 Feb; 125(2):209-16. PubMed ID: 16393674
[TBL] [Abstract][Full Text] [Related]
9. CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.
Nasser MW; Raghuwanshi SK; Malloy KM; Gangavarapu P; Shim JY; Rajarathnam K; Richardson RM
J Biol Chem; 2007 Mar; 282(9):6906-15. PubMed ID: 17204468
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
Almasi S; Aliparasti MR; Farhoudi M; Babaloo Z; Baradaran B; Zamani F; Sadeghi-Bazargani H; Mostafaei S; Hokmabadi ES
Immunol Invest; 2013; 42(8):737-48. PubMed ID: 23876169
[TBL] [Abstract][Full Text] [Related]
12. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
13. CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB.
Wu S; Saxena S; Varney ML; Singh RK
Curr Mol Med; 2017; 17(6):436-449. PubMed ID: 29256349
[TBL] [Abstract][Full Text] [Related]
14. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
Russo RC; Garcia CC; Teixeira MM; Amaral FA
Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
[TBL] [Abstract][Full Text] [Related]
15. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
16. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
17. Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.
Wang RX; Ji P; Gong Y; Shao ZM; Chen S
Breast Cancer Res Treat; 2020 Jun; 181(3):561-570. PubMed ID: 32361849
[TBL] [Abstract][Full Text] [Related]
18. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
Joseph PRB; Sawant KV; Rajarathnam K
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
[TBL] [Abstract][Full Text] [Related]
19. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
[TBL] [Abstract][Full Text] [Related]
20. Probiotics improve re-epithelialization of scratches infected by Porphyromonas gingivalis through up-regulating CXCL8-CXCR1/CXCR2 axis.
Albuquerque-Souza E; Ishikawa KH; Amado PP; Nicoli JR; Holzhausen M; Mayer MPA
Anaerobe; 2021 Dec; 72():102458. PubMed ID: 34547426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]